Market capitalization | $7.12b |
Enterprise Value | $7.85b |
P/E (TTM) P/E ratio | 90.35 |
EV/FCF (TTM) EV/FCF | 51.98 |
EV/Sales (TTM) EV/Sales | 3.89 |
P/S ratio (TTM) P/S ratio | 3.53 |
P/B ratio (TTM) P/B ratio | 5.17 |
Revenue growth (TTM) Revenue growth | -7.76% |
Revenue (TTM) Revenue | $2.02b |
As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.
10 Analysts have issued a Masimo Corporation forecast:
10 Analysts have issued a Masimo Corporation forecast:
Jun '24 |
+/-
%
|
||
Revenue | 2,017 2,017 |
8%
8%
|
|
Gross Profit | 994 994 |
19%
19%
|
|
EBITDA | 259 259 |
15%
15%
|
EBIT (Operating Income) EBIT | 163 163 |
17%
17%
|
Net Profit | 80 80 |
31%
31%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.
Head office | United States |
CEO | Michelle Brennan |
Employees | 9,000 |
Founded | 1989 |
Website | www.masimo.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.